Acter (5536) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
27 Jul, 2026Executive summary
Achieved record revenue of NT$11.6 billion (NT$11,603,182 thousand) and EPS of NT$12.76 in 2026 Q1, with significant YoY growth in all key financial metrics.
Net income attributable to owners of parent was NT$1.58 billion, a 146% increase YoY.
Backlog remains at historical highs, supporting future operations and growth.
Core business focuses on electromechanical engineering and cleanroom integration, with a strong presence in the semiconductor ecosystem.
Comprehensive income totaled NT$2.02 billion, up from NT$747.2 million YoY.
Financial highlights
Operating revenue increased 36% YoY to NT$11.6 billion in 2026 Q1.
Gross profit margin improved to 26% from 18% YoY.
Operating income surged 125% YoY to NT$2.3 billion.
Profit after tax attributable to owners grew 146% YoY to NT$1.58 billion.
Cash and cash equivalents at quarter-end were NT$13.67 billion, up from NT$9.61 billion a year ago.
Outlook and guidance
High backlog of NT$55 billion+ ensures robust future revenue streams.
Market outlook for cleanroom technology and edge AI remains strong, with global cleanroom market CAGR projected at 5.97% through 2032.
Asia-Pacific identified as the fastest-growing region for cleanroom technology.
The Group is evaluating the impact of IFRS 18, to be adopted in Taiwan beginning 2028.
Latest events from Acter
- Q1 2024 delivered strong margins, record backlog, robust cash, and a qualified audit review.5536
Q1 202410 Jun 2026 - Record-high revenue and EPS, strong backlog, and improved gross margin at 22%.5536
Q3 202410 Jun 2026 - Record 2024H1 EPS, strong backlog, and top ESG/ROE metrics, with a qualified auditor review.5536
Q2 202410 Jun 2026 - Record revenue, high backlog, and margin gains drive a strong outlook for 2024.5536
Q4 202410 Jun 2026 - Q1 2025 revenue rose 56% with strong net income and backlog, but audit and cash flow risks remain.5536
Q1 202510 Jun 2026 - Record revenue and EPS in 2025H1, with strong backlog and some credit risk concentration.5536
Q2 202510 Jun 2026 - Record revenue and EPS in 2025 Q1–Q3, with strong backlog and ongoing legal and credit risks.5536
Q3 202510 Jun 2026 - Record revenue, strong backlog, and high ROE drive growth and sustained high dividends.5536
Q4 202510 Jun 2026